Ryan Specialty Group/$RYAN
1D1W1MYTD1Y5YMAX
Capital at risk
About Ryan Specialty Group
Ryan Specialty Holdings Inc is an international specialty insurance intermediary providing specialty products, solutions, and services for insurance brokers, agents, and carriers. The company offers wholesale insurance brokerage and delegated underwriting authority products and services, including distribution, underwriting, product development, administration, and risk management. Its expertise spans property, casualty, professional lines, transportation, personal lines, workers compensation, and employee benefits insurance, across traditional insurance and alternative risk solutions. The company operates in the United States and foreign markets, with the majority of revenue generated from the United States.
- Ticker
- $RYAN
- Sector
- Finance
- Primary listing
- NYSE
- Employees
- 6,171
- Headquarters
- Chicago, United States
- Website
- www.ryanspecialty.com
RYAN Metrics
BasicAdvanced
$4.7B
52.02
$0.73
0.57
$0.51
1.36%
Price and volume
Market cap
$4.7B
Beta
0.57
52-week high
$59.19
52-week low
$29.28
Average daily volume
1.8M
Dividend rate
$0.51
Financial strength
Current ratio
0.998
Quick ratio
0.126
Long term debt to equity
3.658
Total debt to equity
3.747
Dividend payout ratio (TTM)
66.21%
Interest coverage (TTM)
2.96%
Profitability
EBITDA (TTM)
909.371
Gross margin (TTM)
41.49%
Net profit margin (TTM)
3.13%
Operating margin (TTM)
19.73%
Effective tax rate (TTM)
13.97%
Revenue per employee (TTM)
$510,000
Management effectiveness
Return on assets (TTM)
3.45%
Return on equity (TTM)
22.09%
Valuation
Price to earnings (TTM)
52.019
Price to revenue (TTM)
1.542
Price to book
9.09
Price to tangible book (TTM)
-1.1
Price to free cash flow (TTM)
9.826
Free cash flow yield (TTM)
10.18%
Free cash flow per share (TTM)
3.88
Dividend yield (TTM)
1.34%
Forward dividend yield
1.36%
Growth
Revenue change (TTM)
14.84%
Earnings per share change (TTM)
-807.93%
3-year revenue growth (CAGR)
19.46%
3-year earnings per share growth (CAGR)
9.21%
Bulls say / Bears say
Ryan Specialty is still delivering organic growth despite a tougher market. Q2 revenue rose 7.2%, organic growth was 6.7%, and adjusted diluted EPS increased 12.1%, supported by new clients, strong renewal retention and deeper existing relationships. (Nasdaq)
Underwriting Management is becoming a stronger growth engine: its Q2 net commissions and fees rose 12.8%, versus 4.5% for wholesale brokerage, and first-half growth was 24.1%. Ryan is also expanding into reinsurance, alternative capital and benefits, which could reduce reliance on the traditional property cycle. (Nasdaq, Coverager)
Capital returns provide a tangible shareholder catalyst. Ryan repurchased $260 million of shares in Q2 and added $300 million to its authorisation, while its margin outlook improved from the 100–150 basis-point decline given after Q1 to a 50–100 basis-point decline. (Nasdaq, Ryan Specialty)
Growth is slowing while profitability is under pressure: Q2 organic revenue growth eased to 6.7%, adjusted EBITDAC margin fell to 35.7% from 36.1%, and net income dropped 13.1%. Management still expects the full-year margin to decline by 50–100 basis points. (Nasdaq, Morningstar)
Property-market softening is a direct headwind. Management’s outlook includes property rate declines of 25–35% in the most catastrophe-exposed lines, and Q2 results recorded a moderate decline in the property portfolio. (Ryan Specialty, Nasdaq)
The Empower restructuring brings a substantial near-term cost and execution burden: expected charges total $160 million through 2028, with $37.9 million already recognised in the first half of 2026. Operating cash flow also fell to $125.6 million from $210.8 million year on year, before the targeted $80 million of annual savings arrives in 2029. (StockTitan)
Data summarised monthly by Lightyear AI. Last updated on 22 Sept 2026.
Upcoming events
No upcoming events
RYAN News
AllArticlesVideos
Funds containing RYAN
AllGBPUSDEUR
Fund name | Fund size | $RYAN weighting |
|---|---|---|
SPDR S&P 400 US Mid Cap£SPX4 | £4.7B | 0.12% |
SPDR S&P 400 US Mid Cap$SPY4 | $6.3B | 0.12% |
iShares MSCI World Small Cap$WSML | $9B | 0.04% |
iShares MSCI USA Small Cap ESG Enhanced CTB€SXRG | €2.8B | 0.04% |
iShares MSCI World Small Cap€IUSN | €7.8B | 0.04% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.